Relapse related to drug resistance in leprosy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Hansenologia Internationalis (Online) |
Texto Completo: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162 |
Resumo: | The multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic. |
id |
ILSL-1_6145aa1db035b1daa7e6d78689b8fb7e |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/35162 |
network_acronym_str |
ILSL-1 |
network_name_str |
Hansenologia Internationalis (Online) |
repository_id_str |
|
spelling |
Relapse related to drug resistance in leprosyRecidivas associadas à resistência a drogas na hanseníaseMycobacterium lepraehanseníaserecidivaresistência a drogasMycobacterium lepraeleprosyrelapsedrugs resistanceThe multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic.A poliquimioterapia/Organização Mundial da Saúde foi implantada efetivamente no Brasil em 1991, contribuindo drasticamente para redução da taxa de prevalência e cura da hanseníase. No entanto, a sua comprovada eficácia não tem impedido a ocorrência de recidiva da doença. Falha no tratamento, persistência bacilar ou resistência a drogas são fatores que podem ou não estarem associados a ela. O objetivo deste estudo foi verificar a ocorrência de recidiva e associá-la com a presença de cepas resistentes do Mycobacterium leprae entre 28 indivíduos que apresentaram suspeita clínica de recidiva após tratamento por monoterapia sulfônica, esquema da Divisão Nacional de Dermatologia Sanitária ou poliquimioterapia. Biópsias das lesões de pacientes multibacilares, com diagnóstico clínico de recidiva, atendidos por demanda espontânea, foram coletadas para avaliar resistência a drogas por meio da técnica de inoculação em pata de camundongo. Dentre as amostras avaliadas 42,8% apresentaram bacilos sensíveis à dapsona e rifampicina e 10,7% apresentaram resistência à dapsona; não foram isolados bacilos resistentes à rifampicina. A emergência de bacilos resistentes, especialmente à rifampicina, é um alerta para os programas de controle da hanseníase. Monitorar a disseminação destas cepas é importante, pois elas apresentam um sério obstáculo para a eliminação da doença, principalmente em países onde a hanseníase ainda é endêmica.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo2009-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3516210.47878/hi.2009.v34.35162Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 34 No. 1 (2009); 37-42Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 34 n. 1 (2009); 37-421982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33632https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33633Diório, Suzana MadeiraRosa, Patrícia SammarcoBelone, Andréa de Faria FernandesSartori, Beatriz Gomes CarreiraTrino, Lazara MoreiraBaptista, Ida Maria Foschiani DiasMarcos, Elaine Valim CamarinhaBarreto, Jaison AntonioUra, Someiinfo:eu-repo/semantics/openAccess2021-06-05T23:31:41Zoai:ojs.periodicos.saude.sp.gov.br:article/35162Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2021-06-05T23:31:41Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false |
dc.title.none.fl_str_mv |
Relapse related to drug resistance in leprosy Recidivas associadas à resistência a drogas na hanseníase |
title |
Relapse related to drug resistance in leprosy |
spellingShingle |
Relapse related to drug resistance in leprosy Diório, Suzana Madeira Mycobacterium leprae hanseníase recidiva resistência a drogas Mycobacterium leprae leprosy relapse drugs resistance |
title_short |
Relapse related to drug resistance in leprosy |
title_full |
Relapse related to drug resistance in leprosy |
title_fullStr |
Relapse related to drug resistance in leprosy |
title_full_unstemmed |
Relapse related to drug resistance in leprosy |
title_sort |
Relapse related to drug resistance in leprosy |
author |
Diório, Suzana Madeira |
author_facet |
Diório, Suzana Madeira Rosa, Patrícia Sammarco Belone, Andréa de Faria Fernandes Sartori, Beatriz Gomes Carreira Trino, Lazara Moreira Baptista, Ida Maria Foschiani Dias Marcos, Elaine Valim Camarinha Barreto, Jaison Antonio Ura, Somei |
author_role |
author |
author2 |
Rosa, Patrícia Sammarco Belone, Andréa de Faria Fernandes Sartori, Beatriz Gomes Carreira Trino, Lazara Moreira Baptista, Ida Maria Foschiani Dias Marcos, Elaine Valim Camarinha Barreto, Jaison Antonio Ura, Somei |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Diório, Suzana Madeira Rosa, Patrícia Sammarco Belone, Andréa de Faria Fernandes Sartori, Beatriz Gomes Carreira Trino, Lazara Moreira Baptista, Ida Maria Foschiani Dias Marcos, Elaine Valim Camarinha Barreto, Jaison Antonio Ura, Somei |
dc.subject.por.fl_str_mv |
Mycobacterium leprae hanseníase recidiva resistência a drogas Mycobacterium leprae leprosy relapse drugs resistance |
topic |
Mycobacterium leprae hanseníase recidiva resistência a drogas Mycobacterium leprae leprosy relapse drugs resistance |
description |
The multidrugtherapy proposed by the World Health Organization has been effectively implemented in Brazil in 1991. It helped reduce the prevalence and achieve the cure of leprosy. However, its proven efficacy has not prevented the occurrence of relapses in some leprosy patients. Irregular treatment, bacillary persistence or resistance of Mycobacterium leprae to drugs are factors that may be associated with relapse. The objective of this study was assess the occurrence of relapse and associate it with the presence of Mycobacterium leprae resistant strains. In order to do that, 28 individuals who were clinically diagnosed as relapse after treatment with sulphone monotherapy, the National Division of Sanitary Dermatology scheme or multidrugtherapy. Biopsies from lesions of multibacillary patients attended by spontaneous demand were collected to verifyresistance to drugs through the mouse foot pad inoculation technique. Among the samples evaluated 42.8% had bacilli susceptible to dapsone and rifampicin and 10.7% showed resistance to dapsone. No rifampicin resistant bacilli were isolated. The emergence of resistant strains, especially to rifampicin, is a threat to leprosy control programs, therefore, monitoring the spread of these strains is important because resistance pose a serious obstacle to the elimination of disease, particularly in countries where the disease is endemic. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-06-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162 10.47878/hi.2009.v34.35162 |
url |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162 |
identifier_str_mv |
10.47878/hi.2009.v34.35162 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33632 https://periodicos.saude.sp.gov.br/hansenologia/article/view/35162/33633 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 34 No. 1 (2009); 37-42 Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 34 n. 1 (2009); 37-42 1982-5161 reponame:Hansenologia Internationalis (Online) instname:Instituto Lauro de Souza Lima (ILSL) instacron:ILSL |
instname_str |
Instituto Lauro de Souza Lima (ILSL) |
instacron_str |
ILSL |
institution |
ILSL |
reponame_str |
Hansenologia Internationalis (Online) |
collection |
Hansenologia Internationalis (Online) |
repository.name.fl_str_mv |
Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL) |
repository.mail.fl_str_mv |
hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br |
_version_ |
1796797578839326720 |